» Articles » PMID: 20844350

Folate Protection from Congenital Heart Defects Linked with Canonical Wnt Signaling and Epigenetics

Overview
Specialty Pediatrics
Date 2010 Sep 17
PMID 20844350
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Environmental factors, such as drugs, chemicals, or abnormal concentrations of natural metabolites, induce birth defects. Environmental effects on cardiogenesis have been little studied in contrast to neurogenesis. This review presents evidence on three environmental factors: alcohol, the drug lithium, and the metabolite homocysteine, impacting the Wnt/β-catenin pathway during cardiac development and folate protection.

Recent Findings: Animal and epidemiological studies have shown that folate protects the embryo from birth defects. New animal studies demonstrate that folate prevents cardiovascular defects induced by the drug lithium, homocysteine, or alcohol, but protection occurs at a higher concentration than currently used in vitamin supplements. The data indicate that folate in combination with myo-inositol may further reduce the risk of birth defects. Discussion is presented of the cell specification stages that are impacted resulting in cardiac defects, how Wnt/β-catenin signaling is involved, and how folate and myo-inositol additively may protect embryonic pathways. The possible epigenetic role of folate in Wnt/β-catenin signaling is described.

Summary: This review will enable better counseling of women by defining, during early pregnancy, a susceptible window of embryonic exposure leading to a high risk of cardiac defects, and provides a therapeutic means and the necessary timing for prevention of environmentally induced birth defects.

Citing Articles

Environmental Signals.

Porter Jr G Adv Exp Med Biol. 2024; 1441:397-416.

PMID: 38884722 DOI: 10.1007/978-3-031-44087-8_20.


Epigenetics and Congenital Heart Diseases.

Linglart L, Bonnet D J Cardiovasc Dev Dis. 2022; 9(6).

PMID: 35735814 PMC: 9225036. DOI: 10.3390/jcdd9060185.


Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation.

Hamstra S, Roy B, Tiidus P, MacNeil A, Klentrou P, MacPherson R Curr Neuropharmacol. 2022; 21(4):891-910.

PMID: 35236261 PMC: 10227915. DOI: 10.2174/1570159X20666220302151224.


Roles of Wnt Signaling Pathway and ROR2 Receptor in Embryonic Development: An Update Review Article.

Guo R, Xing Q Epigenet Insights. 2022; 15:25168657211064232.

PMID: 35128307 PMC: 8808015. DOI: 10.1177/25168657211064232.


Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Thomford N, Dzobo K, Yao N, Chimusa E, Evans J, Okai E OMICS. 2018; 22(5):301-321.

PMID: 29762087 PMC: 6016577. DOI: 10.1089/omi.2018.0033.


References
1.
Manisastry S, Han M, Linask K . Early temporal-specific responses and differential sensitivity to lithium and Wnt-3A exposure during heart development. Dev Dyn. 2006; 235(8):2160-74. DOI: 10.1002/dvdy.20878. View

2.
Ionescu-Ittu R, Marelli A, Mackie A, Pilote L . Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ. 2009; 338:b1673. PMC: 2682153. DOI: 10.1136/bmj.b1673. View

3.
Villeneuve L, Natarajan R . The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol. 2010; 299(1):F14-25. PMC: 2904177. DOI: 10.1152/ajprenal.00200.2010. View

4.
Sokol R, Delaney-Black V, Nordstrom B . Fetal alcohol spectrum disorder. JAMA. 2003; 290(22):2996-9. DOI: 10.1001/jama.290.22.2996. View

5.
Czeizel A . Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol. 1998; 78(2):151-61. DOI: 10.1016/s0301-2115(98)00061-x. View